Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 19056990.
- Also identified by DOI 10.1126/science.1164511 and PMC identifier 2648820.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
As the immune system develops, T cells are selected or regulated to become tolerant of self antigens and reactive against foreign antigens. In mice, the induction of such tolerance is thought to be attributable to the deletion of self-reactive cells. Here, we show that the human fetal immune system takes advantage of an additional mechanism: the generation of regulatory T cells (Tregs) that suppress fetal immune responses. We find that substantial numbers of maternal cells cross the placenta to reside in fetal lymph nodes, inducing the development of CD4+CD25highFoxP3+ Tregs that suppress fetal antimaternal immunity and persist at least until early adulthood. These findings reveal a form of antigen-specific tolerance in humans, induced in utero and probably active in regulating immune responses after birth.
Medical subject headings
- Fetus
- Immune Tolerance
- Isoantigens
- Lymph Nodes
- Maternal-Fetal Exchange
- T-Lymphocytes, Regulatory